Search

Displaying results 5771 - 5780 of 10000 in total
  1. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

  2. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  3. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational

  4. Drug

    Priralfinamide

    go.drugbank.com/drugs/DB06649
    Investigational

  5. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  6. Drug

    Naluzotan

    go.drugbank.com/drugs/DB05562
    Investigational

  7. Drug

    TC-2696

    go.drugbank.com/drugs/DB05576
    Experimental

    Synonyms: 5-(5-METHOXY-3-PYRIDINYL)-N-METHYL-4-PENTEN-2-AMINE, (2S,4E)-
  8. Drug

    Tirofiban

    go.drugbank.com/drugs/DB00775
    ApprovedInvestigational

    It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. … Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery.

    Synonyms: (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid
  9. Drug

    Solabegron

    go.drugbank.com/drugs/DB06190
    Investigational

    Solabegron (GW-427,353) is a selective β3 adrenoceptor agonist being developed for the treatment of overactive bladder and irritable bowel syndrome.

  10. Drug

    Pirenzepine

    go.drugbank.com/drugs/DB00670
    ApprovedWithdrawn

    It also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. It is generally well tolerated by patients. … It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence.